Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Schedule of Stock Options Activity (Details)

v3.21.1
Stockholders' Equity - Schedule of Stock Options Activity (Details) - Stock Option [Member]
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Stockholders' Equity [Line Items]  
Number of Shares Options Outstanding - Beginning | shares 3,795,000
Number of Shares, Granted | shares
Number of Shares Options Outstanding - Ending | shares 3,795,000
Number of Shares Options Vested and Exercisable | shares 3,273,000
Weighted Average Exercise Price Options Outstanding - Beginning | $ / shares $ 2.21
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price Options Outstanding - Ending | $ / shares 2.21
Weighted Average Exercise Price, Options Vested and Exercisable | $ / shares $ 1.90
Weighted Average Remaining Contractual Life (in Years) - Beginning 3 years 4 months 24 days
Weighted Average Remaining Contractual Life (in Years) - Granted 0 years
Weighted Average Remaining Contractual Life (in Years) - Ending 3 years 2 months 12 days
Weighted Average Remaining Contractual Life (in Years) - Options Vested and Exercisable 2 years 8 months 12 days
Total Intrinsic Value - Beginning | $ $ 26,441
Total Intrinsic Value - Granted | $
Total Intrinsic Value - Ending | $ 19,828
Total Intrinsic Value, Options Vested and Exercisable | $ $ 18,085